Financial relationships between physicians and industry have influence on patient care. Therefore, organizations producing clinical practice guidelines (CPGs) must have policies limiting financial conflicts during guideline development.
R elationships between clinicians and the pharmaceutical and device industries are prevalent. One nationwide study 1 published in 2017 examined the extent of these relationships and found that, in 1 year, 48% of physicians accepted $2.4 billion in industry-related payments. Although, in some cases, these relationships may lead to improved patient care, [2] [3] [4] research suggests that they also foster opportunities for significant financial conflicts of interest (FCOIs). For example, physicians who accepted industry payments were twice as likely to prescribe particular brand name drugs, 4, 5 and they may also assess clinical trials more favorably than physicians who did not accept such payments. 5 One study of more than 279 000 physicians across multiple specialties found that industry-sponsored meals, with a mean value of less than $20, were associated with increased rates of prescribing the brand name medication being promoted at significantly higher costs to Medicare beneficiaries. 4 In addition to these issues, FCOIs have the potential to influence development of clinical practice guidelines (CPGs). [6] [7] [8] [9] [10] [11] The Institute of Medicine (IOM) defines CPGs as "statements that include recommendations intended to optimize patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options".
12(p4) Clinical practice guidelines set a standard of patient care. 13, 14 For this reason, ensuring the integrity of the CPG development process is essential. Because of the need for greater transparency, 15 the Physician Payment Sunshine Act 16 was enacted as part of the Affordable Care Act to provide the public with financial information about physician funding from drug and device companies through Open Payments (https://openpaymentsdata.cms.gov/). Guideline authors are often asked to fully disclose FCOIs; however, evidence suggests that full disclosure is rare. 6 One study examining these disclosure policies found that nearly 50% of CPGs from various specialties cataloged in the National Guideline Clearinghouse did not provide disclosure statements. In addition, nearly half of the CPGs containing disclosures listed authors with industry relationships, and 35% of these authors disclosed an FCOI directly associated with the guideline topic. 6 A similar study investigating professional organizations developing CPGs 17 found that more than half the organizations did not even have an FCOI disclosure policy related to CPGs. The Open Payments database reduces the reliance on authors to self-report FCOIs and supplies the means for an independent evaluation of the extent to which CPG authors have received payments that may compromise CPG development. Initial research indicates that measures are being taken to reduce FCOIs in otolaryngology 18 ; however, the extent of FCOIs pertaining to guideline authors is not as well understood. For example, a 2017 study 1 found that only 2.3% of otolaryngologists as a whole received more than $10 000 in general payments from industry, which is the lowest percentage across all surgical specialties besides obstetrics. Rathi et al 19 found that otolaryngologists received the least amount of nonresearch compensation from industry and had the most restricted ties to industry among all surgical specialties. Another study 18 reported that the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNS/F) spent $450 000 to develop CPGs, with an individual guideline costing the foundation anywhere from $100 000 to $120 000. This expense is conservative, considering the IOM per guideline estimate of $200 000 to $800 000. 12 Although preliminary evidence suggests less influence of industry on otolaryngology compared with other surgical subspecialties, further research is needed to determine the nature of industry payments received by CPG authors and to better understand whether policies adopted by the AAO-HNS/F are being effectively implemented. This study will explore the value, frequency, and types of payments received by the authors of AAO-HNS/F CPGs to promote transparent development practices among CPG authors. We also compare disclosure forms from CPGs with Open Payments data to evaluate accuracy of CPG author disclosures. Finally, we apply relevant IOM standards for CPG development, to which the AAO-HNS/F subscribes, to the CPG panels to determine the extent to which these standards were enforced by the AAO-HNS/F.
Methods
We performed a cross-sectional analysis to examine the nature of industry payments made to physicians who author otolaryngology CPGs. In developing the methods for this study, we consulted Mitchell et al. 5 This study did not meet the regu- Table 1 . Guideline authors were identified within each CPG. Physicians' names and affiliations (private or academic) were extracted and copied into an Excel spreadsheet (Microsoft Corp) by one of us (J.X.C.). Names were alphabetized by last name, and duplicates were removed.
One of us (J.X.C.) extracted data by manually entering the physician's first and last name into the Open Payments search engine. In the event of duplication due to common names, authors were confirmed by using middle initials, company, or location. If the search returned no data or the physician name did not match information provided by Open Payments, the physician was considered to have received no industry payments.
After data extraction, each data element was reviewed for accuracy by another of us (J.H.) by reentering each physician's first and last names into Open Payments, selecting the correct physician from the search returns, and verifying payment data. Any discrepancies were flagged and resolved jointly between both investigators. We also entered the names of each author into Dollars for Docs, 25 which provides an accounting of the companies who contributed to individual authors.
Open Payment data are classified according to the following subcategories 26 : 1. General payments include consulting fees, speaking fees, honoraria, gifts, entertainment, food and beverage, travel and lodging, and education. 2. Research payments include payments associated with a research study, such as basic and applied research and product development. 3. Associated research payments include funding for a research project or study for which the physician is named as a principal investigator.
Ownership and investment interest in companies describe
the actual dollar amount invested and the value of the ownership or investment interest. Records may have 1 or both values associated with them. Subcategories of reimbursement were classified by year. Means and SDs were calculated by year and by subcategory of reimbursement, and the totals were calculated for each year and subcategory. All calculations were initially performed by one of us (J.X.C.) and independently verified by another of us (J.H.). Excel was used for all calculations.
We used the AAO-HNS/F CPG published disclosure statements for each author to evaluate whether the listed companies were consistent with the companies that reported physician payments. One of us (J.H.) extracted the authors' names, disclosure date, and FCOI information, which included the company's name and conflict type (eg, royalties, research, and consultancy). The investigator next searched author's name in the Open Payments database and recorded payment information. Payment dates were compared with the date of the author's disclosure statement. Only payments received before the disclosure date were included. Food and beverage were not considered to be discrepancies because the AAO-HNS/F CPGs did not include them as an FCOI category.
Last, we evaluated the extent to which the AAO-HNS/F enforced the standards in the IOM's Clinical Practice Guidelines written disclosure of all current and planned interests and activities potentially resulting in an FCOI. Standard 2.4 requires members with an FCOI to be a minority of the guideline group and prohibits chairpersons or assistant chairpersons from having FCOIs. We used Open Payments (using the methods described above), the list of authors, and disclosure statements to evaluate whether these standards were enforced.
Results
Five CPGs produced by the AAO-HNS/F met inclusion criteria, and 49 CPG authors were included in the final sample, some of whom served on multiple guidelines. Thirty-four authors were from academic institutions, and 15 were in private practice. All CPGs had a greater proportion of authors from academic institutions, . Each CPG panel except that for Tinnitus contained at least 1 author accepting $10 000 or more from industry. Among these CPG panels containing authors accepting $10 000 or more, Allergic Rhinitis had 5 (31%), Adult Sinusitis had 3 (33%), Acute Otitis Externa had 1 (14%), and Otitis Media With Effusion had 1 (9%). We also ran a subanalysis for the general payments category, excluding authors who received only food and beverage payments. Furthermore, food and beverage payments were excluded in our analysis for authors receiving multiple types of payments (eg, honoraria, consulting fees, and speaking fees). After exclusions, 22 authors were included in the subanalysis, of whom 18 (82%) accepted more than $1000; 7 (32%), more than $10 000; 2 (9%), more than $50 000; and 1 (5%), more than $100 000. Jointly, the authors received a mean (SD) of $21 393 ($48 780). Total payments disbursed was $599 007.32. Figure 1 displays these data.
Our analysis using Dollars for Docs found that a few companies contributed most of the payments to the authors, including Merck & Co; Intersect ENT, Inc; Meda Pharmaceuticals, Inc; and Acclarent, Inc. Of the 22 authors with conflicts, 9 (41%) received payments from companies whose products directly relate to the guidelines. Four authors (18%) received 
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Original Figure 2 displays the data for companies contributing payments to the authors of the Allergic Rhinitis CPG. Because the Otitis Media With Effusion and Adult Sinusitis CPGs included had 1 company with relevant contributions and the Tinnitus CPG had none, we did not include them in Figure 2 . Next, we evaluated the accuracy of self-reported disclosure statements by authors. Of the 49 disclosure statements, 3 (6%) were discrepant when compared with Open Payments data. Undisclosed amounts per authors ranged from approximately $1000 to $13 000.
Finally, we evaluated the extent to which the AAO-HNS/F enforced IOM standards 1, 2.1, and 2.4.
12 The AAO-HNS/F explicitly and publicly disclosed the funding source of each CPG; therefore, the CPGs were in compliance with standard 1. In accordance with standard 2.1, the AAO-HNS/F requires potential authors to disclose FCOIs and explain how FCOIs could affect CPG development; however (as described above), 3 of the 49 authors (6%) did not disclose FCOIs per IOM standard 2.1. Two authors disclosed some FCOIs but did not include every company from which they received payments as reported in Open Payments. One of these authors had nearly $13 000 in undisclosed payments. Another author did not disclose any FCOIs but received significant industry payments totaling $5198.72. The chairperson and most of the assistant chairpersons for each CPG were reported to have received industry payments; therefore, the guideline development group (GDG) for each guideline assessed was not in compliance with IOM standard 2.4. One guideline author and panel member received $3500 in consulting fees and almost $1700 in travel and lodging payments before the date of disclosure; however, the disclosure reported no FCOIs. Another author and panel member on a separate CPG received nearly $1000 for consulting and speaking fees. The other guideline chairpersons and authors accurately reported FCOIs and received no further industry payments during or immediately after guideline development. Seven of 8 chairpersons and assistant chairpersons (88%) received industry payments. Furthermore, another violation of standard 2.4 was found because members with FCOIs represented more than a minority of the GDG.
Discussion
We examined relationships among otolaryngology CPG authors and industry. Our findings demonstrate the following: (1) more than half of each guideline panel received payments from industry; (2) chairpersons had disclosed FCOIs; (3) disclosure statements did not correlate with Open Payments data; and (4) the AAO-HNS/F lacked compliance with IOM standards. Standards not met included members with FCOIs representing more than a minority of the GDG, chairpersons with FCOIs, and authors not properly disclosing financial relationships. Although the amount paid to the otolaryngologists by industry is not significant when compared with amounts paid to other surgical specialties, data suggest that even small payments and gifts can affect physician decision making. 1, 4, 30, 31 For example, although only a few CPG authors received payments of a disproportionately large amount (only 7 authors [14%] accepted more than $50 000), we found that all 5 guidelines assessed had conflicted panel members, ranging from 56% to 88%. This finding is cause for concern, given that on average three quarters of the GDG voting members have FCOIs potentially affecting decision making. This practice is not in compliance with IOM standard 2.4. However, a lack of adherence is not limited to just our findings, because 1 study 17 found that across multiple specialties, none of the evaluated CPGs were in compliance with IOM standards. CPG development needs improvement, and because otolaryngology is among the specialties with the lowest monetary amounts of FCOIs, 1,19 the field is poised to be a leader in producing CPGs adherent to IOM standards. We should note that GDGs contained nonphysician voting members, who were not included in the study. We found that Several different methods for managing financial conflicts among industry and academia have been posited, including disclosure, institutional review, and prohibition of conflict. Although providing accessible information for the public to examine, conflict disclosure alone is not likely to mitigate competing interests that lead to bias. However, institutional review provides academic centers the ability to prohibit individuals from certain activities and decisions in which their competing interest may introduce bias. Many professional societies recommend this approach.
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36,37
Pisano et al, 38 who include senior academic leaders and an unpaid board member of a health care company, recommend that leaders at academic institutions be prohibited from holding paid positions with health care companies unless the position is outside the scope of the academic role. Regulation and management of financial conflicts is no small task and will most likely be handled on a case-by-case basis. Our study also found that for every guideline assessed, each CPG had conflicts in leadership in the chairperson, the assistant chairperson, or both. This finding reveals noncompliance with another tenet of IOM standard 2.4 and raises concern about the independence and transparency of these guidelines. Chairpersons are identified to lead the GDG, with responsibilities that include guiding panel discussions, selecting panel members, and delegating writing assignments. 39 24 the mechanism for authors to do so seems to be unclear.
Implementing a clear mechanism for authors to update their disclosure after guideline publication is an opportunity for improving the guideline development process regarding transparency. Finally, we recommend that the AAO-HNS/F abide by their own policy as well as the IOM standards when selecting GDG chairpersons. We also recommend the addition of a medical ethicist to the review board who would evaluate the FCOI disclosure forms and could then inform the leadership administration which potential guideline members and chairpersons have relevant FCOIs. Implementing these practices would promote selection of a guideline panel that complies with IOM standards and the AAO-HNS/ F's own policies.
Limitations
Limitations of this study include possible human error or inaccurate data from the Open Payments site. For example, multiple clinicians could have the same name, leading to potential inaccuracies during data extraction. Some physicians were not retrievable during searches, which could mean that the physician did not receive payments or that parties responsible for reporting payments failed to do so. 44 If the latter is the case, data will be misleading because no record of payment exists. In addition, Open Payments allots a 45-day period to dispute payments reported by the site. This process has proved to be inefficient. Fewer than 5% of physicians reviewed their data during the program's inaugural year 45, 46 ; therefore, possible errors were not likely to have been rectified. In addition, Open Payments only reports information from US-based physi-report of even more frequent potential COI in dermatology, in which 82% of authors had received some payment, 51% had received more than $10 000, and 45% had inaccurate disclosure of COI. Andreatos et al 8 found that 523 of 1329 guideline authors (39.4%) identified from the National Guideline Clearinghouse website had received more than $5000 from at least 1 health careassociated entity based on Open Payments data. Only 10.7% of these 523 authors accurately disclosed COI. The study by Horn et al 5 alerts us to include potential COI as part of our critical assessment of guideline recommendations. It is concerning that several AAO-HNS guideline authors received large payments from companies related to their guideline topic and even more troubling that disclosure of conflicts for a few was not accurate. However, the frequency and effect of relevant financial COI in AAO-HNS CPGs remains uncertain. Even if we assume 
